Novartis is working to expand production of its in-demand prostate cancer drug Pluvicto, announcing Friday it has completed an application to the Food and Drug Administration for approval of a New Jersey factory that manufactures the medicine.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,